Market by Product, Application, End-user, and Country | Forecast 2021-2028
The Asia-Pacific digital genome market is expected to progress with a CAGR of 10.52% in terms of revenue throughout the estimated years between 2021 and 2028.
Report scope can be customized per your requirements. Request For Customization
The
countries assessed in this market include:
• China
• Japan
• India
• Australia & New Zealand
• South Korea
• ASEAN countries
• Rest of APAC countries
The
Government of China is supporting the development of genomics, and with the
government’s backing, players in the Chinese market are investing significantly
in genetic research. For instance, the Chinese Academy of Sciences launched an
initiative for the development of precision medicine in 2016. It also invested
close to $9 billion in a project to sequence more than 100 million human
genomes by the year 2030.
In
China, genomics is booming due to the rising demand for genetic sequencing.
Moreover, the country has listed genomics as a key strategic field in its 13th
five-year plan. In addition, collaborations between the local and international
entities are taking place for developing the genomics infrastructure. All these
factors are together helping the Chinese market for digital genome to flourish
in the coming years.
Japan
is working on strengthening its healthcare system to support the betterment of
its public. The government of the nation is focusing on the development of
genomics, and for this, it has initiated various programs and institutes in the
country. For instance, the Japan Agency for Medical Research and Development is
promoting research in the field of genomic medicine and also for creating
next-generation precision medicine through several programs. These factors are
accelerating the progress of the Japanese digital genome market.
Illumina
Inc develops, manufactures, and distributes products and solutions for multiple
life sciences methods and procedures. Life sciences and clinical genomics are
the principal markets in which the company operates. Illumina offers an
extensive range of products to help in applications like drug development, advanced
disease research, and molecular test development. The company also offers
services such as genotyping, whole-genome sequencing, and microarray projects. The
company distributes its products directly to customers in the Asia-Pacific.
Market By Type, Application, E ..
VIEW REPORT
Market By Device Type, Therape ..
VIEW REPORT
Market By Type, Application, T ..
VIEW REPORT
Market By Technology, Applicat ..
VIEW REPORT
Market By Application, Type, E ..
VIEW REPORT
Market by Therapeutics, Diagno ..
VIEW REPORT
Market by Type, Application, E ..
VIEW REPORT1. ASIA-PACIFIC
DIGITAL GENOME MARKET - SUMMARY
2. INDUSTRY
OUTLOOK
2.1. PORTER’S
FIVE FORCES MODEL
2.1.1. THREAT
OF NEW ENTRANTS
2.1.2. THREAT
OF SUBSTITUTE PRODUCTS
2.1.3. BARGAINING
POWER OF BUYERS
2.1.4. BARGAINING
POWER OF SUPPLIERS
2.1.5. COMPETITIVE
RIVALRY
2.2. IMPACT
OF COVID-19 ON DIGITAL GENOME MARKET
2.3. MARKET
ATTRACTIVENESS INDEX
2.4. VENDOR
LANDSCAPE
2.5. KEY
INSIGHTS
2.6. KEY
DRIVERS
2.6.1. PROLIFERATING
BURDEN OF CHRONIC DISEASES
2.6.2. CONTINUOUS
FUNDING BY THE MANUFACTURERS AND GOVERNMENT IN THE FIELD OF GENOMICS
2.7. KEY
RESTRAINTS
2.7.1. SECURITY
RISKS ASSOCIATED WITH DIGITAL GENOME
2.7.2. LACK
OF SKILLED PROFESSIONALS IN THE FIELD OF GENOME TECHNOLOGY
2.8. KEY
OPPORTUNITIES
2.8.1. TECHNOLOGICAL
ADVANCEMENTS
2.8.2. PREVAILING
AWARENESS IN THE DEVELOPING ECONOMIES REGARDING DNA SEQUENCING TECHNOLOGIES
3. DIGITAL
GENOME MARKET OUTLOOK - BY PRODUCT
3.1. SEQUENCING
AND ANALYZER INSTRUMENTS
3.2. DNA/RNA
ANALYSIS
3.3. SEQUENCING
AND ANALYSIS SOFTWARE
3.4. SEQUENCING
CHIPS
3.5. SAMPLE
PREP INSTRUMENTS
4. DIGITAL
GENOME MARKET OUTLOOK - BY APPLICATION
4.1. DIAGNOSTICS
4.2. DRUG
DISCOVERY
4.3. ACADEMIC
RESEARCH
4.4. PERSONALIZED
MEDICINE
4.5. AGRICULTURAL
4.6. OTHER
APPLICATIONS
5. DIGITAL
GENOME MARKET OUTLOOK - BY END-USER
5.1. DIAGNOSTICS
AND FORENSIC LABS
5.2. ACADEMIC
RESEARCH INSTITUTES
5.3. HOSPITALS
5.4. OTHER
END-USERS
6. DIGITAL
GENOME MARKET - ASIA-PACIFIC
6.1. COUNTRY
ANALYSIS
6.1.1. CHINA
6.1.2. JAPAN
6.1.3. AUSTRALIA
& NEW ZEALAND
6.1.4. INDIA
6.1.5. SOUTH
KOREA
6.1.6. ASEAN
COUNTRIES
6.1.7. REST
OF ASIA-PACIFIC
7. COMPANY
PROFILE
7.1. QIAGEN
NV
7.2. OXFORD
NANOPORE TECHNOLOGIES LTD
7.3. BECTON,
DICKINSON, AND COMPANY (BD)
7.4. ILLUMINA
INC
7.5. THERMO
FISHER SCIENTIFIC INC
7.6. PACIFIC
BIOSCIENCE
7.7. BIO-RAD
LABORATORIES INC
7.8. F.
HOFFMANN-LA ROCHE
7.9. PERKINELMER
INC
7.10. REGENERON
PHARMACEUTICALS
7.11. BIOMERIEUX
SA
7.12. ABBOTT
LABORATORIES
7.13. AGILENT
TECHNOLOGIES INC.
7.14. INSCRIPTA
8. RESEARCH
METHODOLOGY & SCOPE
8.1. RESEARCH
SCOPE & DELIVERABLES
8.1.1. OBJECTIVES
OF STUDY
8.1.2. SCOPE
OF STUDY
8.2. SOURCES
OF DATA
8.2.1. PRIMARY
DATA SOURCES
8.2.2. SECONDARY
DATA SOURCES
8.3. RESEARCH
METHODOLOGY
8.3.1. EVALUATION
OF PROPOSED MARKET
8.3.2. IDENTIFICATION
OF DATA SOURCES
8.3.3. ASSESSMENT
OF MARKET DETERMINANTS
8.3.4. DATA
COLLECTION
8.3.5. DATA
VALIDATION & ANALYSIS
TABLE
1: ASIA-PACIFIC DIGITAL GENOME
MARKET, BY COUNTRY, 2021-2028 (IN $ MILLION)
TABLE
2: VENDOR LANDSCAPE
TABLE
3: ASIA-PACIFIC DIGITAL GENOME
MARKET, BY PRODUCT, 2021-2028 (IN $ MILLION)
TABLE
4: ASIA-PACIFIC DIGITAL GENOME
MARKET, BY APPLICATION, 2021-2028 (IN $ MILLION)
TABLE
5: ASIA-PACIFIC DIGITAL GENOME
MARKET, BY END-USER, 2021-2028 (IN $ MILLION)
TABLE
6: ASIA-PACIFIC DIGITAL GENOME
MARKET, BY COUNTRY, 2021-2028 (IN $ MILLION)
FIGURE
1: ASIA-PACIFIC DIGITAL GENOME MARKET
2021-2028 (IN $ MILLION)
FIGURE
2: ASIA-PACIFIC DIGITAL GENOME MARKET,
BY SEQUENCING AND ANALYZER INSTRUMENTS, 2021-2028 (IN $ MILLION)
FIGURE
3: ASIA-PACIFIC DIGITAL GENOME MARKET,
BY DNA/RNA ANALYSIS, 2021-2028 (IN $ MILLION)
FIGURE
4: ASIA-PACIFIC DIGITAL GENOME MARKET,
BY SEQUENCING AND ANALYSIS SOFTWARE, 2021-2028 (IN $ MILLION)
FIGURE
5: ASIA-PACIFIC DIGITAL GENOME MARKET,
BY SEQUENCING CHIPS, 2021-2028 (IN $ MILLION)
FIGURE
6: ASIA-PACIFIC DIGITAL GENOME MARKET,
BY SAMPLE PREP INSTRUMENTS, 2021-2028 (IN $ MILLION)
FIGURE
7: ASIA-PACIFIC DIGITAL GENOME MARKET,
BY DIAGNOSTICS, 2021-2028 (IN $ MILLION)
FIGURE
8: ASIA-PACIFIC DIGITAL GENOME MARKET,
BY DRUG DISCOVERY, 2021-2028 (IN $ MILLION)
FIGURE
9: ASIA-PACIFIC DIGITAL GENOME MARKET,
BY ACADEMIC RESEARCH, 2021-2028 (IN $ MILLION)
FIGURE
10: ASIA-PACIFIC DIGITAL GENOME MARKET,
BY PERSONALIZED MEDICINE, 2021-2028 (IN $ MILLION)
FIGURE
11: ASIA-PACIFIC DIGITAL GENOME MARKET,
BY AGRICULTURAL, 2021-2028 (IN $ MILLION)
FIGURE
12: ASIA-PACIFIC DIGITAL GENOME MARKET,
BY OTHER APPLICATIONS, 2021-2028 (IN $ MILLION)
FIGURE
13: ASIA-PACIFIC DIGITAL GENOME MARKET,
BY DIAGNOSTICS AND FORENSIC LABS, 2021-2028 (IN $ MILLION)
FIGURE
14: ASIA-PACIFIC DIGITAL GENOME MARKET,
BY ACADEMIC RESEARCH INSTITUTES, 2021-2028 (IN $ MILLION)
FIGURE
15: ASIA-PACIFIC DIGITAL GENOME MARKET,
BY HOSPITALS, 2021-2028 (IN $ MILLION)
FIGURE
16: ASIA-PACIFIC DIGITAL GENOME MARKET,
BY OTHER END-USERS, 2021-2028 (IN $ MILLION)
FIGURE
17: ASIA-PACIFIC DIGITAL GENOME MARKET
2021-2028 (IN $ MILLION)
FIGURE
18: CHINA DIGITAL GENOME MARKET 2021-2028
(IN $ MILLION)
FIGURE
19: JAPAN DIGITAL GENOME MARKET 2021-2028
(IN $ MILLION)
FIGURE
20: AUSTRALIA & NEW ZEALAND DIGITAL
GENOME MARKET 2021-2028 (IN $ MILLION)
FIGURE
21: INDIA DIGITAL GENOME MARKET 2021-2028
(IN $ MILLION)
FIGURE
22: SOUTH KOREA DIGITAL GENOME MARKET
2021-2028 (IN $ MILLION)
FIGURE
23: ASEAN COUNTRIES DIGITAL GENOME MARKET
2021-2028 (IN $ MILLION)
FIGURE
24: REST OF ASIA-PACIFIC DIGITAL GENOME
MARKET 2021-2028 (IN $ MILLION)